A c-ras(Ha) mutation in the metastasis of a human papillomavirus (HPV)- 18 positive penile squamous cell carcinoma suggests a cooperative effect between HPV-18 and c-ras(HA) activation in malignant progression

Cancer

Volumn 83, Issue 1, 1998, Pages 122-129

  Leis, Paula F ^a   Stevens, Kristin R ^a   Baer, Susan C ^a   Kadmon, Dov ^a   Goldberg, Leonard H ^a   Wang, Xiao Jing ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

C ras(Ha); Human papillomavirus 18; Metastasis; P53 tumor suppressor gene; Penis; Squamous cell carcinoma

Indexed keywords

BLEOMYCIN; METHOTREXATE; PROTEIN P53; VINCRISTINE; VIRUS DNA; KERATIN;

ADULT; ARTICLE; CASE REPORT; COOPERATION; GENE MUTATION; HUMAN; INGUINAL LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; ONCOGENE H RAS; PENIS CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; WART VIRUS; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; METASTASIS; MIDDLE AGED; MUTATION; ONCOGENE RAS; PAPILLOMA VIRUS; PENIS TUMOR; VIROLOGY;

CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GENES, RAS; HUMANS; KERATINS; MALE; MIDDLE AGED; MUTATION; PAPILLOMAVIRIDAE; PENILE NEOPLASMS;

EID: 0032105496     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980701)83:1<122::AID-CNCR16>3.0.CO;2-Z     Document Type: Article

References (50)

1. Broker TR, Chow LT, Chin MT, Rhodes CR, Wolinsky SM, Whitbeck A, et al. A molecular portrait of human papillomavirus carcinogenesis. Cancer Cells 1989;7:197-208.
2. zur Hausen H. Papillomaviruses in human cancers. Mol Carcinog 1988;1:147-50.
3. zur Hausen H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res 1989;49:4677-81.
4. Howley PM. Role of the human papillomaviruses in human cancer. Cancer Res 1991;51(Suppl):5019-22.
5. Cupp MR, Malek RS, Goellner JR, Smith TF, Espy MJ. The detection of human papillomavirus deoxyribonucleic acid in intraepithelial, in situ, verrucous and invasive carcinoma of the penis. J Urol 1995;154:1024-9.
6. Gregoire L, Cubilla AL, Reuter VE, Haas GP, Lancaster WD. Preferential association of human papillomavirus with high-grade histologic variants of penile-invasive squamous cell carcinoma. J Natl Cancer Inst 1995;87:1705-9.
7. Higgins GD, Uzelin DM, Phillips GE, Villa LL, Burrell CJ. Differing prevalence of human papillomavirus RNA in penile dysplasias and carcinomas may reflect differing etiologies. Am J Clin Pathol 1992;97:272-8.
8. Masih AS, Stoler MH, Farrow GM, Johansson SL. Human papillomavirus in penile squamous cell lesions. A comparison of an isotopic RNA and two commercial nonisotopic DNA in situ hybridization methods. Arch Pathol Lab Med 1993;117:302-7.
9. Siegel JF, Mellinger BC. Human papillomavirus in the male patient. Urol Clin North Am 1992;19:83-91.
10. zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991;184:9-13.
11. Villa LL, Lopes A. Human papillomavirus DNA sequences in penile carcinomas in Brazil. Int J Cancer 1986;37:853-5.
12. Barbosa MS, Schlegel R. The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene 1989;4:1529-32.
13. Chen T-M, Pecoraro G, Defendi V. Genetic analysis of in vitro progression of human papillomavirus-transfected human cervical cells. Cancer Res 1993;53:1167-71.
14. Kurman RJ, Schiffman MH, Lancaster WD, Reid R, Jenson AB, Temple GF, et al. Analysis of individual human papillomavirus types in cervical neoplasia. A possible role for type 18 in rapid progression. Am J Obstet Gynecol 1988;159:293-6.
15. Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy R. Schiller IT. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J 1989;8:3905-10.
16. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A, et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985;314:111-4.
17. Schneider-Gädicke A, Schwarz E. Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J 1986;5: 2285-92.
18. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990;248:76-9.
19. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990; 63:1129-36.
20. Dyson N, Howley PM, Münger K, Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989;243:934-7.
21. Huang H-JS, Yee L-K, Shew J-Y, Chen P-L. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 1988;242:1563-6.
22. Finlay CA, Hinds PW, Levine AJ. The p53 proto-oncogene can act as a suppressor of transformation. Cell 1989;57: 1083-93.
23. Bishop JM. The molecular genetics of cancer. Science 1987; 235:305-11.
24. Chen R-M, Defendi V. Functional interaction of p53 with HPV18 E6, c-myc, and H-ras in 3T3 cells. Oncogene 1992;7: 1541-7.
25. Crook T, Storey A, Almond N, Osborn K, Crawford L. Human papillomavirus type 16 cooperates with activated ras and fos oncogenes in the hormone-dependent transformation of primary mouse cells. Proc Natl Acad Sci USA 1988; 85:8820-4.
26. Crook T, Wrede D, Vousden KH. p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene 1991;4:873-5.
27. Scheffner M, Münger K, Byrne JC, Howley PM. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 1991;88:5523-7.
28. Crook T, Vousden KH. Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens. EMBO J 1992;11:3935-40.
29. DiPaolo JA, Woodworth CD, Popescu NC, Notario V, Doniger J. Induction of human cervical squamous cell carcinoma by sequential transfection with human papillomavirus 16 DNA and viral Harvey ras. Oncogene 1989;4:395-9.
30. Ha-activated papillomas. Cell Growth Differ 1994;5:667-75.
31. Lamb P, Crawford L. Characterization of the human p53 gene. Mol Cell Biol 1986;6:1379-85.
32. Fasano O, Taparowsky E, Fiddes J. Sequence and structure of the coding region of the human H-ras-1 gene from T24 bladder carcinoma cells. J Mol Appl Genet 1983;2:173-80.
33. Weiss RA, Eichner RA, Sun TT. Monoclonal antibody analysis of keratin expression in epidermal diseases. A 48-and 56-kilodalton keratin as molecular markers for hyperproliferative keratinocytes. J Cell Biol 1984;98:1397-406
34. Hanash KA, Furlow WI, Utz DC, Harrison EG. Carcinoma of the penis: a clinicopathologic study. J Urol 1970;104:291-7.
35. Malek RS, Goellner JR, Smith TF, Espy MJ, Cupp MR. Human papillomavirus infection and intraepithelial, in situ, and invasive carcinoma of penis. Urology 1993;42:159-70.
36. Horenblas S, van Tinteren H, Delemarre JFM, Moonen LMF, Lustig V, van Waardenburg EW. Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes. J Urol 1993;149:492-7.
37. H genes mutated at codon 61. Cell 1986;44:167-76.
38. Bos JL. ras oncogenes in human cancer. Cancer Res 1988;49: 4602-9.
39. el-Deiry WS. Role of oncogenes in resistance and killing by cancer therapeutic agents. Curr Opin Oncol 1997;9:79-87.
40. Peters GJ, Wets M, Keepers YP, Oskam R, van Ark-Otte J, Noordhuis P, et al. Transformation of mouse fibroblasts with the oncogenes H-ras OR trk is associated with pronounced changes in drug sensitivity and metabolism. Int J Cancer 1993;54:450-5.
41. Sanchez-Prieto R, Vargas JA, Carnero A, Marchetti E, Romero J, Durantez A, et al. Modulation of cellular chemoresistance in keratinocytes by activation of different oncogenes. Int J Cancer 1995;60:235-43.
42. Nelson MA, Futscher BW, Kinsella T, Wymer J, Bowden GT. Detection of mutant Ha-ras genes in chemically initiated mouse skin epidermis before the development of benign tumors. Proc Natl Acad Sci USA 1992;89:6398-402.
43. Leon J, Kamino H, Steinberg JJ, Pellicer A. H-ras activation in benign and self-regressing skin tumors (keratoacanthomas) in both humans and an animal model system. Mol Cell Biol 1988;8:786-93.
44. Bianchi AB, Aldaz M, Conti CJ. Nonrandom duplication of the chromosome bearing a mutated Ha-ras-1 allele in mouse skin tumors. Proc Natl Acad Sci USA 1990;87:6902-6.
45. Buchmann A, Ruggeri B, Klein-Szanto AJP, Balmain A. Progression of squamous carcinoma cells to spindle carcinomas of mouse skin is associated with an imbalance of H-ras alleles on chromosome 7. Cancer Res 1991;51:4097-101.
46. Hayashi T, Hachisuga T, Iwasaka T, Fukuds K, Okuma Y, Tokoyama M, et al. Expression of ras oncogene product and EGF receptor in cervical squamous cell carcinomas and its relationship to lymph node involvement. Gynecol Oncol 1991;40:147-51.
47. Pelisson I, Soler C, Chignol MC, Euvrard S, Chardonnet Y. Human papillomaviruses and cellular oncogenes (c-myc, c-Ha-ras) in cutaneous and mucosal lesions in transplantation recipients. Bull Cancer (Paris) 1992;79:471-82.
48. Pelisson I, Soler C, Pechoux C, Chignol MC, Viac J, Euvrard S, et al. c-myc and c-Ha-ras cellular oncogenes and human papillomaviruses in benign and malignant cutaneous lesions. J Dermatol Sci 1992;3:56-67.
49. Denko NC, Giaccia AJ, Stringer JR, Stambrook PJ. The human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell cycle. Proc Natl Acad Sci USA 1994;91:5124-8.
50. Mitsuhashi JR, Filmus BJ, Shirasawa S, Sasazuki T, Kerbel RS. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res 1995;55:4575-80.